Zuko Komisa A potential game-changer in the fight against HIV has emerged, as early safety trials for a revolutionary annual injection have yielded positive results. The drug, lenacapavir, designed to prevent HIV replication within cells, has successfully passed crucial initial safety tests, bringing hope for a simpler, more accessible form … Continue reading Annual HIV prevention injection passes early safety trial